미국의 비뇨기과 시장 : 규모, 점유율, 동향 분석(2024-2030년) - MedSuite

Urology Market Size, Share & Trends Analysis | United States | 2024-2030 | MedSuite | Includes: Urinary Incontinence Devices, Stone Management Devices, and 7 more

US $ 7,995 ￦ 11,220,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,995 ￦ 12,623,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 9,995 ￦ 14,026,000

PDF (Corporate License)

PDF 보고서를 동일 기업(해외)의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄는 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

미국 비뇨기과 시장 규모는 5.7%의 CAGR로 확대되어 2030년에는 65억 달러에 육박할 것으로 예상됩니다.

병원이 외래환자 시설 인수를 계속 확대하고 그룹구매조직(GPO)의 영향력이 커지는 가운데 비뇨기과에서는 진료비 인하가 계속되고 있어 평균판매가격(ASP)이 지속적인 압력에 직면해 향후 시장 성장을 저해할 수 있습니다.

NeoTract의 UroLift(R)는 2013년 미국에서 출시된 이후 전립선비대증(BPH) 치료제로 비뇨기과 의사들 사이에서 빠르게 확산되고 있으며, 유럽, 캐나다, 호주 등 다른 지역에서도 인기를 얻고 있습니다. 2017년 Teleflex가 NeoTract를 인수하면서 Teleflex의 광범위한 판매망을 통해 UroLift(R)의 시장 침투력을 강화했으며, 2021년 9월에는 UroLift Advanced Tissue Control(ATC)(R) 및 UroLift(R) 2 시스템의 출시는 초기 임상적 성공에 기반하여 환자의 안전성을 높이고 물류 부담을 줄이기 위한 것입니다.

이 보고서는 미국의 비뇨기과 시장에 대해 조사했으며, 시장 개요와 함께 부문별 동향, 시장 촉진요인 및 저해요인, 경쟁 시장 점유율 분석, 시장 진입 기업 개요 등의 정보를 전해드립니다.

목차

주요 요약

조사 방법

세계의 비뇨기과 시장에 대한 COVID-19의 영향

• 소개
• 지역 프로파일
• 시장 부문별 분석

질환 개요

• 기본적인 해부학
• 질병 치료와 진단
• 환자 인구통계

제품 평가

• 소개
• 제품 포트폴리오
• 규제상 문제와 리콜
• 임상시험

미국의 비뇨기과 기기 시장 개요

• 소개
• 시장 개요와 동향 분석
• 성장 촉진요인과 억제요인
• 경쟁 시장 점유율 분석
• 인수합병
• 기업 개요
  • Becton Dickinson
  • Boston Scientific
  • Cardinal Health
  • Coloplast
  • Cook Medical
  • Elekta
  • Ethicon
  • Karl Storz
  • Laborie
  • Medline
  • Olympus
  • Siemens Healthineers
  • Teleflex
• SWOT 분석

요실금 기기 시장

결석 관리 기기 시장

BPH 치료 기기 시장

비뇨기 내시경 시장

전립선암 치료 기기 시장

요역동학 장비 시장

신루술 기기 시장

남성 생식 의료 시장

요도 가이드와이어 시장

ksm

영문 목차

영문목차

CAGR of 5.7%, reaching nearly $6.5 billion by the end of the forecast period.

The comprehensive report on the U.S. market for urological devices covers various segments, including urinary incontinence devices, stone management devices, benign prostate hyperplasia (BPH) treatment devices, urological endoscopes, prostate cancer treatment devices, urodynamic equipment, nephrostomy devices, men's reproductive health devices, and urinary guidewires.

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Value & Growth Trends

10 Year Scope

Market Drivers & Limiters for Each Segment

Competitive Analysis with Market Shares for Each Segment

Recent Mergers & Acquisitions

Disease Overviews and Demographic Information

Company Profiles, Product Portfolios and SWOT for Top Competitors

As hospitals continue to expand their acquisitions of outpatient facilities and group purchasing organizations (GPOs) grow their influence, coupled with ongoing cuts in reimbursement rates in the urology sector, Average Selling Prices (ASPs) are likely to face ongoing pressure, potentially stifling future market growth.

Since its U.S. debut in 2013, NeoTract's UroLift(R) has seen rapid adoption among urologists for the treatment of Benign Prostatic Hyperplasia (BPH), mirroring its popularity in regions including Europe, Canada, and Australia. This minimally invasive procedure offers a quick recovery, enhancing its appeal. The 2017 acquisition of NeoTract by Teleflex has bolstered UroLift(R)'s market penetration, benefiting from Teleflex's extensive sales network. In September 2021, the launch of the UroLift Advanced Tissue Control (ATC)(R) and UroLift(R) 2 systems aimed to enhance patient safety and reduce logistical burdens, building on the original's clinical success.

MARKET SEGMENTATION SUMMARY

While this report suite contains all applicable market data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the specific market segment research that you need. You can view all these included reports and segmentation here:

Urinary Incontinence Devices Market - MedCore - The market for urinary incontinence treatments includes urinary catheters, urethral bulking agents, incontinence management devices, and urinary bags.

Stone Management Devices - MedCore - The total market for stone management devices includes ESWL capital equipment, ISWL equipment, Holmium lasers, Thulium lasers, stone fragment retrieval devices, ureteral stents, access sheaths.

BPH Treatment Devices - MedCore - The BPH treatment device market includes devices used for TURP, TUMT, TUNA, temporary prostatic stent, laser BPH, UroLift(R), Rezum(R) and iTind(R) procedures.

Urological Endoscope - MedCore - The urological endoscope market includes cystoscopes, ureteroscopes, resectoscopes and nephroscopes.

Prostate Cancer Treatment Devices - MedCore - The prostate cancer treatment device market includes brachytherapy devices, cryotherapy ablation devices, and hydrogel rectal spacers.

Urodynamic Equipment Market - MedCore - The market for urodynamic equipment includes urodynamic equipment and urodynamic consumables.

Nephrostomy Devices - MedCore - The market for nephrostomy devices includes percutaneous nephrostomy sets, nephrostomy balloon catheters and nephrostomy drainage tubes.

Men's Reproductive Health Market - MedCore - The total market for men's reproductive health treatment devices includes inflatable erectile dysfunction devices, malleable erectile dysfunction devices, vacuum assisted erectile dysfunction devices, and testicular implants.

Urinary Guidewire Market - MedCore - The market for guidewires includes all guidewires to be used in urological procedures CAGR of 5.7%, reaching nearly $6.5 billion by the end of the forecast period.

The comprehensive report on the U.S. market for urological devices covers various segments, including urinary incontinence devices, stone management devices, benign prostate hyperplasia (BPH) treatment devices, urological endoscopes, prostate cancer treatment devices, urodynamic equipment, nephrostomy devices, men's reproductive health devices, and urinary guidewires.

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Value & Growth Trends

10 Year Scope

Market Drivers & Limiters for Each Segment

Competitive Analysis with Market Shares for Each Segment

Recent Mergers & Acquisitions

Disease Overviews and Demographic Information

Company Profiles, Product Portfolios and SWOT for Top Competitors

As hospitals continue to expand their acquisitions of outpatient facilities and group purchasing organizations (GPOs) grow their influence, coupled with ongoing cuts in reimbursement rates in the urology sector, Average Selling Prices (ASPs) are likely to face ongoing pressure, potentially stifling future market growth.

Since its U.S. debut in 2013, NeoTract's UroLift(R) has seen rapid adoption among urologists for the treatment of Benign Prostatic Hyperplasia (BPH), mirroring its popularity in regions including Europe, Canada, and Australia. This minimally invasive procedure offers a quick recovery, enhancing its appeal. The 2017 acquisition of NeoTract by Teleflex has bolstered UroLift(R)'s market penetration, benefiting from Teleflex's extensive sales network. In September 2021, the launch of the UroLift Advanced Tissue Control (ATC)(R) and UroLift(R) 2 systems aimed to enhance patient safety and reduce logistical burdens, building on the original's clinical success.

MARKET SEGMENTATION SUMMARY

While this report suite contains all applicable market data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the specific market segment research that you need. You can view all these included reports and segmentation here:

Urinary Incontinence Devices Market - MedCore - The market for urinary incontinence treatments includes urinary catheters, urethral bulking agents, incontinence management devices, and urinary bags.

Stone Management Devices - MedCore - The total market for stone management devices includes ESWL capital equipment, ISWL equipment, Holmium lasers, Thulium lasers, stone fragment retrieval devices, ureteral stents, access sheaths.

BPH Treatment Devices - MedCore - The BPH treatment device market includes devices used for TURP, TUMT, TUNA, temporary prostatic stent, laser BPH, UroLift(R), Rezum(R) and iTind(R) procedures.

Urological Endoscope - MedCore - The urological endoscope market includes cystoscopes, ureteroscopes, resectoscopes and nephroscopes.

Prostate Cancer Treatment Devices - MedCore - The prostate cancer treatment device market includes brachytherapy devices, cryotherapy ablation devices, and hydrogel rectal spacers.

Urodynamic Equipment Market - MedCore - The market for urodynamic equipment includes urodynamic equipment and urodynamic consumables.

Nephrostomy Devices - MedCore - The market for nephrostomy devices includes percutaneous nephrostomy sets, nephrostomy balloon catheters and nephrostomy drainage tubes.

Men's Reproductive Health Market - MedCore - The total market for men's reproductive health treatment devices includes inflatable erectile dysfunction devices, malleable erectile dysfunction devices, vacuum assisted erectile dysfunction devices, and testicular implants.

Urinary Guidewire Market - MedCore - The market for guidewires includes all guidewires to be used in urological procedures.

TABLE OF CONTENT

TABLE of CONTENTS

List of Figures

List of Charts

executive summary

U.S. Urological Device Market Overview

Competitive Analysis

Market Trends

Market Developments

Procedure Included

Procedure Codes Investigated

Markets Included

Key Report Updates

Version History

research methodology

• Step 1: Project Initiation & Team Selection
• Step 2: Prepare Data Systems and Perform Secondary Research
• Step 3: Preparation for Interviews & Questionnaire Design
• Step 4: Performing Primary Research
• Step 5: Research Analysis: Establishing Baseline Estimates
• Step 6: Market Forecast and Analysis
• Step 7: Identify Strategic Opportunities
• Step 8: Final Review and Market Release
• Step 9: Customer Feedback and Market Monitoring

impact of covid-19 on THE U.S. Urological Device Market

• 2.1 Introduction
• 2.2 Analysis By Market Segment
  • 2.2.1 Worst Case Scenario
  • 2.2.2 Base Case Scenario
  • 2.2.3 Best Case Scenario

Disease overview

• 3.1 Basic Anatomy
  • 3.1.1 Urinary System
    • 3.1.1.1 Male Urinary System
    • 3.1.1.2 Female Urinary System
• 3.2 Disease Treatment and Diagnostics
  • 3.2.1 Benign Prostatic Hyperplasia
  • 3.2.2 Urinary Incontinence
  • 3.2.3 Urinary Tract Infections
  • 3.2.4 Kidney Stones
  • 3.2.5 Bladder Prolapse
  • 3.2.6 Overactive Bladder
  • 3.2.7 Prostatitis
  • 3.2.8 Men's Reproductive Health
  • 3.2.9 Cancer
    • 3.2.9.1 Prostate Cancer
    • 3.2.9.2 Bladder Cancer
• 3.3 Patient Demographics
  • 3.3.1 Benign Prostatic Hyperplasia
  • 3.3.2 Urinary Incontinence
  • 3.3.3 Urinary Tract Infections
  • 3.3.4 Kidney Stones
  • 3.3.5 Bladder Prolapse
  • 3.3.6 Overactive Bladder
  • 3.3.7 Prostatitis
  • 3.3.8 Men's Reproductive Health
  • 3.3.9 Cancer
    • 3.3.9.1 Prostate Cancer
    • 3.3.9.2 Bladder Cancer

Product Assessment

• 4.1 Introduction
• 4.2 Product Portfolios
  • 4.2.1 Urinary Incontinence
    • 4.2.1.1 Urinary Catheters
    • 4.2.1.1.1 Intermittent Catheters
    • 4.2.1.1.2 Foley Catheters
    • 4.2.1.1.3 Male External Catheters
    • 4.2.1.1.4 Female External Catheters
    • 4.2.1.2 Urethral Bulking Agents
    • 4.2.1.3 Female Incontinence Slings
    • 4.2.1.4 Male Implantable Devices
    • 4.2.1.4.1 Male Incontinence Slings
    • 4.2.1.4.2 Artificial Urinary Sphincters
    • 4.2.1.5 Urine Bags
    • 4.2.1.5.1 Leg Bags
    • 4.2.1.5.2 Bedside Drainage Bags
  • 4.2.2 Stone Management
    • 4.2.2.1 ESWL Equipment
    • 4.2.2.2 Intracorporeal Lithotripsy Equipment
    • 4.2.2.3 Holmium Lasers
    • 4.2.2.4 Stone Fragment Retrieval Devices
    • 4.2.2.5 Ureteral Stents
    • 4.2.2.6 Thulium Lasers and Fibers
  • 4.2.3 BPH Treatment
    • 4.2.3.1 TURP
    • 4.2.3.2 TUMT
    • 4.2.3.3 TUNA
    • 4.2.3.4 Prostatic Stents
    • 4.2.3.5 Novel BPH Solutions
    • 4.2.3.5.1 Rezum(TM)
    • 4.2.3.5.2 UroLift(R)
    • 4.2.3.5.3 iTind
    • 4.2.3.6 Laser BPH
    • 4.2.3.6.1 Photoselective Vaporization of the Prostate (PVP)
    • 4.2.3.6.2 Laser Vaporization of the Prostate
    • 4.2.3.6.3 Laser Ablation of the Prostate
    • 4.2.3.6.4 Laser Resection of the Prostate
    • 4.2.3.6.5 Laser Enucleation of the Prostate
  • 4.2.4 Urological Endoscopes
    • 4.2.4.1 Cystoscopes
    • 4.2.4.2 Ureteroscopes
    • 4.2.4.3 Resectoscopes
    • 4.2.4.4 Nephroscopes
  • 4.2.5 Prostate Cancer Treatment
    • 4.2.5.1 Brachytherapy
    • 4.2.5.1.1 HDR Implants
    • 4.2.5.1.2 LDR Implants
    • 4.2.5.2 Cryotherapy
  • 4.2.6 Urodynamics
    • 4.2.6.1 Urodynamic Equipment
    • 4.2.6.2 Urodynamic Consumables
    • 4.2.6.2.1 Water-Charged Catheters
    • 4.2.6.2.2 Air-Charged Catheters
    • 4.2.6.2.3 Fiber-Optic Catheters
  • 4.2.7 Nephrostomy
    • 4.2.7.1 Percutaneous Nephrostomy Drainage Tubes & Sets
    • 4.2.7.2 Nephrostomy Balloon Catheters
  • 4.2.8 Men's Reproductive Health
    • 4.2.8.1 Penile Implants
    • 4.2.8.1.1 Inflatable
    • 4.2.8.1.2 Malleable
    • 4.2.8.1.3 Vacuum
    • 4.2.8.2 Testicular Implants
  • 4.2.9 Urinary Guidewires
• 4.3 Regulatory Issues and Recalls
  • 4.3.1 Urinary Incontinence Device Market FDA Recalls
  • 4.3.2 Stone Management Device Market FDA Recalls
  • 4.3.3 BPH Treatment Device Market FDA Recalls
  • 4.3.4 Urological Endoscope Market FDA Recalls
  • 4.3.5 Prostate Cancer Treatment Device Market FDA Recalls
  • 4.3.6 Nephrostomy Device Market FDA Recalls
  • 4.3.7 Men's Reproductive Health Device Market FDA Recalls
• 4.4 Clinical Trials
  • 4.4.1 Urinary Incontinence Device Market Clinical Trials
  • 4.4.2 Stone Management Devices Market Clinical Trials
  • 4.4.3 BPH Treatment Device Market Clinical Trials
  • 4.4.4 Urological Endoscope Market Clinical Trials
  • 4.4.5 Prostate Cancer Treatment Device Market Clinical Trials
  • 4.4.6 Men's Reproductive Health Device Market Clinical Trials

U.S. Urological Device Market Overview

• 5.1 Introduction
• 5.2 Market Overview & Trend Analysis
• 5.3 Drivers and Limiters
  • 5.3.1 Market Drivers
  • 5.3.2 Market Limiters
• 5.4 Competitive Market Share Analysis
• 5.5 Mergers and Acquisitions
• 5.6 Company Profiles
  • 5.6.1 Becton Dickinson
  • 5.6.2 Boston Scientific
  • 5.6.3 Cardinal Health
  • 5.6.4 Coloplast
  • 5.6.5 Cook Medical
  • 5.6.6 Elekta
  • 5.6.7 Ethicon
  • 5.6.8 Karl Storz
  • 5.6.9 Laborie
  • 5.6.10 Medline
  • 5.6.11 Olympus
  • 5.6.12 Siemens Healthineers
  • 5.6.13 Teleflex
• 5.7 SWOT Analysis
  • 5.7.1 Becton Dickinson
  • 5.7.2 Boston Scientific
  • 5.7.3 Cardinal Health
  • 5.7.4 Coloplast
  • 5.7.5 Cook Medical
  • 5.7.6 Elekta
  • 5.7.7 Ethicon
  • 5.7.8 Karl Storz
  • 5.7.9 Laborie
  • 5.7.10 Medline
  • 5.7.11 Olympus
  • 5.7.12 Siemens Healthineers
  • 5.7.13 Teleflex

Procedure Numbers

• 6.1 Procedure Codes Investigated
• 6.2 Procedure Overview
  • 6.2.1 Urinary Incontinence Management Procedures
    • 6.2.1.1 Male Urinary Incontinence Management Procedures
    • 6.2.1.2 Female Urinary Incontinence Management Procedures
  • 6.2.2 Stone Management Procedures
    • 6.2.2.1 ESWL Procedures
    • 6.2.2.2 Transurethral Procedures
    • 6.2.2.3 Ureteral Stent Procedures
    • 6.2.2.4 PCNL Procedures
  • 6.2.3 Ureteroscopy Procedures
  • 6.2.4 Cystoscopy Procedures
  • 6.2.5 BPH Procedures
    • 6.2.5.1 BPH Patient Statistics
    • 6.2.5.2 BPH Procedures by Segment
    • 6.2.5.3 BPH Procedures by Care Setting
    • 6.2.5.3.1 Hospital Procedures
    • 6.2.5.3.2 Ambulatory Surgery Center (ASC) Procedures
    • 6.2.5.3.3 Office Procedures
  • 6.2.6 Prostate Cancer Treatment Procedures
    • 6.2.6.1 Prostate Cancer Patient Statistics
    • 6.2.6.2 Prostate Cancer Treatment Procedures
    • 6.2.6.2.1 Watchful Waiting Procedures
    • 6.2.6.2.2 Prostatectomy Procedures
    • 6.2.6.2.3 Ablation Procedures
    • 6.2.6.2.4 Radiation Therapy Procedures
  • 6.2.7 Urodynamic Testing Procedures
    • 6.2.7.1 Cystometrogram Procedures
    • 6.2.7.2 Uroflowmetry Procedures
  • 6.2.8 Nephrostomy Procedures
  • 6.2.9 Erectile Dysfunction Management Procedures

Urinary Incontinence Device Market

• 7.1 Introduction
• 7.2 Market Overview
• 7.3 Market Analysis and Forecast
  • 7.3.1 Urinary Catheter Market
    • 7.3.1.1 Intermittent Catheter Market
    • 7.3.1.1.1 Coated Intermittent Catheter Market
    • 7.3.1.1.2 Uncoated Intermittent Catheter Market
    • 7.3.1.1.3 Closed-System Intermittent Catheter Market
    • 7.3.1.2 Foley Catheter Market
    • 7.3.1.2.1 Latex Foley Catheter Market
    • 7.3.1.2.2 Latex-Free Foley Catheter Market
    • 7.3.1.2.3 Closed-System Foley Tray Market
    • 7.3.1.3 External Catheter Market
    • 7.3.1.3.1 Male External Catheter Market
    • 7.3.1.3.2 Female External Catheter Market
  • 7.3.2 Urethral Bulking Agent Market
    • 7.3.2.1 Male Urethral Bulking Agent Market
    • 7.3.2.2 Female Urethral Bulking Agent Market
  • 7.3.3 Incontinence Management Device Market
    • 7.3.3.1 Female Incontinence Sling Market
    • 7.3.3.2 Male Implantable Incontinence Device Market
    • 7.3.3.2.1 Male Incontinence Sling Market
    • 7.3.3.2.2 Male Artificial Urinary Sphincter Market
  • 7.3.4 Urinary Bag Market
    • 7.3.4.1 Bedside Urine Drainage Bag Market
    • 7.3.4.2 Leg Urine Drainage Bag Market
• 7.4 Drivers and Limiters
  • 7.4.1 Market Drivers
  • 7.4.2 Market Limiters
• 7.5 Competitive Market Share Analysis

Stone Management Device Market

• 8.1 Introduction
• 8.2 Market Overview
• 8.3 Market Analysis and Forecast
  • 8.3.1 ESWL Equipment Market
  • 8.3.2 ISWL Equipment Market
  • 8.3.3 Holmium Laser Market
    • 8.3.3.1 Holmium Laser Equipment Market
    • 8.3.3.1.1 High-Power Holmium Laser Equipment Market
    • 8.3.3.1.2 Low-Power Holmium Laser Equipment Market
    • 8.3.3.2 Holmium Laser Fiber Market
    • 8.3.3.2.1 Reusable Holmium Laser Fiber Market
    • 8.3.3.2.2 Single-Use Holmium Laser Fiber Market
  • 8.3.4 Thulium Laser Market
    • 8.3.4.1 Thulium Laser Equipment Market
    • 8.3.4.2 Thulium Laser Fiber Market
  • 8.3.5 Stone Fragment Retrieval Device Market
    • 8.3.5.1 Nitinol Stone Fragment Retrieval Device Market
    • 8.3.5.2 Stainless-Steel Stone Fragment Retrieval Device Market
  • 8.3.6 Ureteral Stent Market
  • 8.3.7 Access Sheath Market
• 8.4 Drivers and Limiters
  • 8.4.1 Market Drivers
  • 8.4.2 Market Limiters
• 8.5 Competitive Market Share Analysis

BPH Treatment Device Market

• 9.1 Introduction
  • 9.1.1 Treatments
    • 9.1.1.1 TURP
    • 9.1.1.2 Minimally Invasive Treatments
    • 9.1.1.3 Laser BPH Treatments
    • 9.1.1.3.1 Photoselective Vaporization of the Prostate (PVP)
    • 9.1.1.3.2 Laser Vaporization of the Prostate
    • 9.1.1.3.3 Laser Ablation of the Prostate
    • 9.1.1.3.4 Laser Resection of the Prostate
    • 9.1.1.3.5 Laser Enucleation of the Prostate
  • 9.1.2 Comparison of TURP and Laser BPH Procedures
  • 9.1.3 Emerging Technologies
• 9.2 Market Overview
• 9.3 Market Analysis and Forecast
  • 9.3.1 TURP Market
    • 9.3.1.1 Total Monopolar Electrode Market
    • 9.3.1.1.1 Monopolar Electrode Loop Market
    • 9.3.1.1.2 Monopolar Coagulating Resector Electrode Market
    • 9.3.1.1.3 Monopolar Vaporizing Electrode Market
    • 9.3.1.1.4 Other Monopolar Electrode Device Market
    • 9.3.1.2 Total Bipolar Electrode Market
    • 9.3.1.2.1 Bipolar Electrode Loop Market
    • 9.3.1.2.2 Bipolar Vaporizing Electrode Market
    • 9.3.1.2.3 Other Bipolar Electrode Device Market
  • 9.3.2 TUMT Market
    • 9.3.2.1 TUMT Equipment Market
    • 9.3.2.2 TUMT Consumables Market
  • 9.3.3 TUNA Market
    • 9.3.3.1 TUNA Equipment Market
    • 9.3.3.2 TUNA Consumables Market
  • 9.3.4 Temporary Prostatic Stent Market
  • 9.3.5 Laser BPH Market
    • 9.3.5.1 Laser BPH Equipment Market
    • 9.3.5.1.1 High-Power Holmium Laser Equipment Market
    • 9.3.5.1.2 Thulium Laser Equipment Market
    • 9.3.5.2 Laser BPH Fiber Market
    • 9.3.5.2.1 Water Targeting Fiber Market
    • 9.3.5.2.2 Hemoglobin Targeting Fiber Market
  • 9.3.6 UroLift Market
  • 9.3.7 Rezum Market
    • 9.3.7.1 Rezum Equipment Market
    • 9.3.7.2 Rezum Consumables Market
  • 9.3.8 iTind Market
• 9.4 Drivers and Limiters
  • 9.4.1 Market Drivers
  • 9.4.2 Market Limiters
• 9.5 Competitive Market Share Analysis

Urological Endoscope Market

• 10.1 Introduction
• 10.2 Market Overview
  • 10.2.1 Urological Endoscope Market by Segment
  • 10.2.2 Urological Endoscope Market by Condition
• 10.3 Market Analysis and Forecast
  • 10.3.1 Urological Endoscope Market
  • 10.3.2 Cystoscope Market
    • 10.3.2.1 Single-Use Cystoscope Market
    • 10.3.2.2 Reusable Cystoscope Market
    • 10.3.2.2.1 Reusable Rigid Cystoscope Market
    • 10.3.2.2.2 Reusable Flexible Cystoscope Market
    • 10.3.2.2.3 New Flexible Cystoscope Market
    • 10.3.2.2.4 Refurbished Flexible Cystoscope Market
  • 10.3.3 Ureteroscope Market
    • 10.3.3.1 Single-Use Flexible Ureteroscope Market
    • 10.3.3.2 Reusable Ureteroscope Market
    • 10.3.3.2.1 Semi-Rigid Ureteroscope Market
    • 10.3.3.2.2 Reusable Flexible Ureteroscope Market
    • 10.3.3.2.3 New Flexible Ureteroscope Market
    • 10.3.3.2.4 Refurbished Flexible Ureteroscope Market
  • 10.3.4 Resectoscope Market
    • 10.3.4.1 New Resectoscope Market
    • 10.3.4.2 Refurbished Resectoscope Market
  • 10.3.5 Nephroscope Market
    • 10.3.5.1 New Nephroscope Market
    • 10.3.5.2 Refurbished Nephroscope Market
• 10.4 Drivers and Limiters
  • 10.4.1 Market Drivers
  • 10.4.2 Market Limiters
• 10.5 Competitive Market Share Analysis

Prostate Cancer Treatment Device Market

• 11.1 Introduction
• 11.2 Market Overview
• 11.3 Market Analysis and Forecast
  • 11.3.1 Brachytherapy Device Market
    • 11.3.1.1 HDR Brachytherapy Market
    • 11.3.1.1.1 Afterloader Market
    • 11.3.1.1.2 Afterloader Service Market
    • 11.3.1.2 LDR Brachytherapy Market
    • 11.3.1.2.1 LDR Seed Market
    • 11.3.1.2.2 LDR Needle Market
  • 11.3.2 Cryotherapy Ablation Device Market
    • 11.3.2.1 Cryotherapy Ablation Device Market
    • 11.3.2.2 Cryotherapy Ablation Device Rental Market
    • 11.3.2.3 Cryotherapy Ablation Probe Market
  • 11.3.3 Hydrogel Rectal Spacer Device Market
• 11.4 Drivers and Limiters
  • 11.4.1 Market Drivers
  • 11.4.2 Market Limiters
• 11.5 Competitive Market Share Analysis

Urodynamic Equipment Market

• 12.1 Introduction
• 12.2 Market Overview
• 12.3 Market Analysis and Forecast
  • 12.3.1 Urodynamic Equipment Market
    • 12.3.1.1 Hospital Urodynamic Capital Equipment Market
    • 12.3.1.2 Medical Office Urodynamic Capital Equipment Market
  • 12.3.2 Urodynamic Consumables Market
    • 12.3.2.1 Air-Charged Catheter Market
    • 12.3.2.2 Water-Filled Catheter Market
    • 12.3.2.3 Fiber Optic Catheter Market
• 12.4 Drivers and Limiters
  • 12.4.1 Market Drivers
  • 12.4.2 Market Limiters
• 12.5 Competitive Market Share Analysis

Nephrostomy Device Market

• 13.1 Introduction
• 13.2 Market Overview
• 13.3 Market Analysis and Forecast
  • 13.3.1 Percutaneous Nephrostomy Set Market
  • 13.3.2 Nephrostomy Balloon Catheter Market
  • 13.3.3 Nephrostomy Drainage Tube Market
• 13.4 Drivers and Limiters
  • 13.4.1 Market Drivers
  • 13.4.2 Market Limiters
• 13.5 Competitive Market Share Analysis

Men's Reproductive Health Market

• 14.1 Introduction
  • 14.1.1 Low Testosterone Pharmaceutical Delivery
• 14.2 Market Overview
• 14.3 Market Analysis and Forecast
  • 14.3.1 Inflatable Erectile Dysfunction Device Market
  • 14.3.2 Malleable Erectile Dysfunction Device Market
  • 14.3.3 Vacuum Erection Device Market
  • 14.3.4 Testicular Implant Market
• 14.4 Drivers and Limiters
  • 14.4.1 Market Drivers
  • 14.4.2 Market Limiters
• 14.5 Competitive Market Share Analysis

Urinary Guidewire Market

• 15.1 Introduction
• 15.2 Market Analysis and Forecast
• 15.3 Drivers and Limiters
  • 15.3.1 Market Drivers
  • 15.3.2 Market Limiters
• 15.4 Competitive Market Share Analysis

관련자료